Healio
Healio

TCT
ByErik Swain
ByScott Buzby
ByB. Hadley Wilson, MD, FACC

Read more

September 23, 2022
11 min watch
Save

VIDEO: Wilson discusses PROTECTED TAVR, CLASP IID trials and more from TCT 2022

ByErik Swain
ByScott Buzby
ByB. Hadley Wilson, MD, FACC
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BOSTON — In this Healio video exclusive, B. Hadley Wilson, MD, FACC, discussed late-breaking research in transcatheter aortic valve replacement, and more presented at TCT 2022.

Wilson, who is executive vice chair of Atrium Health’s Sanger Heart and Vascular Institute and clinical professor of medicine at UNC School of Medicine, provided his perspective on the PROTECTED TAVR and CLASP IID trials as well as findings from analyses of the TVT and U.K. National Registries.

Watch the video for more.

References:

  • Alkhouli M, et al. Late-Breaking Clinical Science in Structural Heart Disease: Session I, in Collaboration With The New England Journal of Medicine. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
  • Giblett J, et al. Late-Breaking Science in Structural Heart Disease: Session II, in Collaboration With The European Heart Journal/EuroIntervention. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
  • Kapadia SR, et al. Late-Breaking Clinical Science in Structural Heart Disease: Session I, in Collaboration with The New England Journal of Medicine. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
  • Kapadia SR, et al. N Engl J Med. 2022;doi:10.1056/NEJMoa2204961.
  • Koulogiannis KP, et al. Late-Breaking Clinical Science in Structural Heart Disease: Session I, in Collaboration With The New England Journal of Medicine. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
  • Lim DS, et al. JACC Cardiovasc Interv. 2022;doi:10.1016/j.jcin.2022.09.005.
  • Simard T, et al. J Am Coll Cardiol. 2022;doi:10.1016/j.jacc.2022.09.006.
Sources/Disclosures

Collapse
Source:

Healio Interviews

Disclosures: Wilson reports no relevant financial disclosures.

Read more about

transcatheter aortic valve replacement
transcatheter mitral valve repair
cerebral infarction
periprocedural stroke
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

 

Related Content